Home LiteratureArticle Details
PMID: 15584863 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S. Review

Hitting multiple targets with multimeric ligands.

Expert opinion on therapeutic targets ·Vol. 8 ·No. 6 ·2004-12-00 ·Pages 565-86

Handl HL, Vagner J, Han H, Mash E, Hruby VJ, Gillies RJ

Abstract

Multimeric ligands consist of multiple monomeric ligands attached to a single backbone molecule, creating a multimer that can bind to multiple receptors or targets simultaneously. Numerous examples of multimeric binding exist within nature. Due to the multiple and simultaneous binding events, multimeric ligands bind with an increased affinity compared to their corresponding monomers. Multimeric ligands may provide opportunities in the field of drug discovery by providing enhanced selectivity and affinity of binding interactions, thus providing molecular-based targeted therapies. However, gaps in our knowledge currently exist regarding the quantitative measures for important design characteristics, such as flexibility, length and orientation of the inter-ligand linkers, receptor density and ligand sequence. In this review, multimeric ligand binding in two separate phases is examined. The prerecruitment phase describes the binding of one ligand of a multimer to its corresponding receptor, an event similar to monomeric ligand binding. This results in transient increases in the local concentration of the other ligands, leading to apparent cooperativity. The postrecruitment phase only occurs once all receptors have been aligned and bound by their corresponding ligand. This phase is analogous to DNA-DNA interactions in that the stability of the complex is derived from physical orientation. Multiple factors influence the kinetics and thermodynamics of multimeric binding, and these are discussed.

MeSH Terms
Antineoplastic Agents/chemistry,pharmacology,therapeutic use DNA/drug effects Drug Carriers Drug Design Kinetics Ligands Models, Chemical Molecular Structure Nucleic Acid Denaturation/drug effects Nucleic Acid Hybridization/drug effects Polymers/chemistry,pharmacokinetics,pharmacology Protein Binding Receptors, Drug/drug effects Structure-Activity Relationship Substrate Specificity Thermodynamics
Chemicals
Antineoplastic Agents Drug Carriers Ligands Polymers Receptors, Drug DNA
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Handl Heather L
Arizona Cancer Center, Department of Biochemistry and Molecular Biophysics, 1515 N. Campbell Avenue, Tucson, AZ 85724-5024, USA.
Vagner Josef
Han Haiyong
Mash Eugene
Hruby Victor J
Gillies Robert J
Article Info
Journal
Expert opinion on therapeutic targets
Abbr.
Expert Opin Ther Targets
ISSN
1744-7631
Published
2004-12-00
Pages
565-86
Language
English
Region
England
NLM ID
101127833
Subset
IM
Grants
NCI NIH HHS · R01 CA95944 · United States
NCI NIH HHS · R33 CA83148 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com